Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study

Objective This study aimed to identify determinants of immunological recovery following highly active antiretroviral therapy (HAART) among severely immunosuppressed patients at enrolment to care in Northern Ethiopia.Methods A retrospective study.Setting The study was done in Tigray Region, Northern...

Full description

Saved in:
Bibliographic Details
Main Authors: Awtachew Berhe Woldu, Abraham Aregay Desta, Tewolde Wubayehu Woldearegay, Kibriti Mehari Kidane, Yemane Weldu Bahta, Kiros Fenta Ajemu, Ataklti Gebretsadik Woldegebriel, Asfawosen Aregay Berhe, Nega Mamo Bezabih
Format: Article
Language:English
Published: BMJ Publishing Group 2020-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/10/8/e038741.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850057754614431744
author Awtachew Berhe Woldu
Abraham Aregay Desta
Tewolde Wubayehu Woldearegay
Kibriti Mehari Kidane
Yemane Weldu Bahta
Kiros Fenta Ajemu
Ataklti Gebretsadik Woldegebriel
Asfawosen Aregay Berhe
Nega Mamo Bezabih
author_facet Awtachew Berhe Woldu
Abraham Aregay Desta
Tewolde Wubayehu Woldearegay
Kibriti Mehari Kidane
Yemane Weldu Bahta
Kiros Fenta Ajemu
Ataklti Gebretsadik Woldegebriel
Asfawosen Aregay Berhe
Nega Mamo Bezabih
author_sort Awtachew Berhe Woldu
collection DOAJ
description Objective This study aimed to identify determinants of immunological recovery following highly active antiretroviral therapy (HAART) among severely immunosuppressed patients at enrolment to care in Northern Ethiopia.Methods A retrospective study.Setting The study was done in Tigray Region, Northern Ethiopia.Participants The study was done among severely immunosuppressed (<200 CD4 cells/mm3) individuals at initial enrolment to care and whose samples were sent for viral load determination from April 2015 to March 2019 in Tigray Health Research Institute.Main outcomes The main outcome variable was immunological recovery, modelled using binary logistic regression.Results Among the 9687 patients with severe immunosuppression at enrolment, 2746 (28.35%, 95% CI 27.45% to 29.26%) had immunological recovery following HAART for at least 6 months. Male gender (adjusted OR (AOR)=0.50, p<0.001), age 20–34 years old (AOR=0.33, p<0.001), age ≥50 years old (AOR=0.26, p<0.001), WHO clinical stage III (OR=0.68, p=0.036) and viral non-suppression (AOR=0.38, p<0.001) were strong predictors of immunological failure.Conclusions Immunological recovery following HAART was low among severely immunosuppressed individuals at enrolment to care. Gender, age, WHO stage III and viral non-suppression were determinants of immunological recovery. Male patients, adolescents and virally non-suppressed patients should be identified as groups at higher risk for immunological failure. Therefore, greater support and intensive counselling should be prioritised among adolescents, men and virally non-suppressed patients for better immunological recovery.
format Article
id doaj-art-fd7027e08f6d4d8faabe14cd94036651
institution DOAJ
issn 2044-6055
language English
publishDate 2020-08-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-fd7027e08f6d4d8faabe14cd940366512025-08-20T02:51:20ZengBMJ Publishing GroupBMJ Open2044-60552020-08-0110810.1136/bmjopen-2020-038741Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective studyAwtachew Berhe Woldu0Abraham Aregay Desta1Tewolde Wubayehu Woldearegay2Kibriti Mehari Kidane3Yemane Weldu Bahta4Kiros Fenta Ajemu5Ataklti Gebretsadik Woldegebriel6Asfawosen Aregay Berhe7Nega Mamo Bezabih8School of Public Health, Ayder College of Health Sciences, Mekelle University, Mekelle, EthiopiaDirectorate of Public Health Research and Emergency Management, Tigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaMicrobiology, Mekelle University College of Health Sciences, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaTigray Health Research Institute, Mekelle, Tigray, EthiopiaObjective This study aimed to identify determinants of immunological recovery following highly active antiretroviral therapy (HAART) among severely immunosuppressed patients at enrolment to care in Northern Ethiopia.Methods A retrospective study.Setting The study was done in Tigray Region, Northern Ethiopia.Participants The study was done among severely immunosuppressed (<200 CD4 cells/mm3) individuals at initial enrolment to care and whose samples were sent for viral load determination from April 2015 to March 2019 in Tigray Health Research Institute.Main outcomes The main outcome variable was immunological recovery, modelled using binary logistic regression.Results Among the 9687 patients with severe immunosuppression at enrolment, 2746 (28.35%, 95% CI 27.45% to 29.26%) had immunological recovery following HAART for at least 6 months. Male gender (adjusted OR (AOR)=0.50, p<0.001), age 20–34 years old (AOR=0.33, p<0.001), age ≥50 years old (AOR=0.26, p<0.001), WHO clinical stage III (OR=0.68, p=0.036) and viral non-suppression (AOR=0.38, p<0.001) were strong predictors of immunological failure.Conclusions Immunological recovery following HAART was low among severely immunosuppressed individuals at enrolment to care. Gender, age, WHO stage III and viral non-suppression were determinants of immunological recovery. Male patients, adolescents and virally non-suppressed patients should be identified as groups at higher risk for immunological failure. Therefore, greater support and intensive counselling should be prioritised among adolescents, men and virally non-suppressed patients for better immunological recovery.https://bmjopen.bmj.com/content/10/8/e038741.full
spellingShingle Awtachew Berhe Woldu
Abraham Aregay Desta
Tewolde Wubayehu Woldearegay
Kibriti Mehari Kidane
Yemane Weldu Bahta
Kiros Fenta Ajemu
Ataklti Gebretsadik Woldegebriel
Asfawosen Aregay Berhe
Nega Mamo Bezabih
Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
BMJ Open
title Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
title_full Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
title_fullStr Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
title_full_unstemmed Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
title_short Determinants of immunological recovery following HAART among severely immunosuppressed patients at enrolment to care in Northern Ethiopia: a retrospective study
title_sort determinants of immunological recovery following haart among severely immunosuppressed patients at enrolment to care in northern ethiopia a retrospective study
url https://bmjopen.bmj.com/content/10/8/e038741.full
work_keys_str_mv AT awtachewberhewoldu determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT abrahamaregaydesta determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT tewoldewubayehuwoldearegay determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT kibritimeharikidane determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT yemaneweldubahta determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT kirosfentaajemu determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT atakltigebretsadikwoldegebriel determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT asfawosenaregayberhe determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy
AT negamamobezabih determinantsofimmunologicalrecoveryfollowinghaartamongseverelyimmunosuppressedpatientsatenrolmenttocareinnorthernethiopiaaretrospectivestudy